<DOC>
	<DOCNO>NCT02799914</DOCNO>
	<brief_summary>Post market clinical follow-up study Sinus-venous stent . Patients venous iliofemoral occlusive disease treat Sinus-venous stent . This observational study provide 1 year data safety efficacy .</brief_summary>
	<brief_title>Evaluation Sinus-Venous Stent Treatment Iliofemoral Venous Occlusive Disease</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>1 . Age study entry least 18 year . 2 . Patient must sign informed consent form prior indexprocedure . 3 . Patient suffers acute chronic venous occlusive disease indicate treated venous stent . 4 . Target lesion locate femoral vein , common femoral vein , external iliac vein , common iliac vein . 1 . Intolerance anticoagulant medication . 2 . Contraindication prolong anticoagulant treatment . 3 . Life expectancy less 1 year . 4 . Target vessel stented . 5 . Coagulopathy know uncorrectable bleeding diathesis . 6 . Recent ( &lt; 1 year ) pulmonary embolism . 7 . Pregnancy . 8 . Known hypersensitivity nitinol and/or nickel . 9 . Known , suspect unable comply study protocol ( e.g . permanent address , know noncompliant present unstable psychiatric history ) . 10 . Legal incapacity and/or circumstance render patient unable understand nature , scope possible impact study . 11 . Patients custody juridical order . 12 . Patients agree transmission cod data within liability documentation notification . 13 . Close affiliation investigational site : e.g . close relative investigator possibly dependent person ( e.g . employee student investigational site ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>